| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stroke, Vol 12, 40-46, Copyright © 1981 by American Heart Association
A Terent, R Hallgren, P Venge and K Bergstrom
Serial determinations of beta 2-microglobulin, lactoferrin and lysozyme in
CSF were performed in 14 patients with acute cerebrovascular lesions.
Marked elevations were noted in patients with cerebral bleeding or
hemorrhagic infarction. Patients with infarction without signs of bleeding
or with cerebrovascular lesions undetectable by computed tomography also
had an increase in these proteins. The increases in CSF of beta
2-microglobulin, lactoferrin and lysozyme could not be explained by a
damaged blood-brain barrier but was believed to be a local product of the
central nervous system. Peak levels of lactoferrin and lysozyme were noted
on day 2-3 after onset of symptoms. Lactoferrin then declined while
lysozyme remained elevated for another few days. beta 2-microglobulin
gradually increased reaching peak levels on day 4-5 and remained elevated
even 2 weeks after the onset of symptoms. We suggest that the increases of
lactoferrin, lysozyme and beta 2-microglobulin reflect various inflammatory
reactions mediated by granulocytes, macrophages and lymphocytes,
respectively.
ARTICLES
Lactoferrin, lysozyme, and beta 2-microglobulin in cerebrospinal fluid. Elevated levels in patients with acute cerebrovascular lesions as indices of inflammation
This article has been cited by other articles:
![]() |
C. Fillebeen, L. Descamps, M.-P. Dehouck, L. Fenart, M. Benaissa, G. Spik, R. Cecchelli, and A. Pierce Receptor-mediated Transcytosis of Lactoferrin through the Blood-Brain Barrier J. Biol. Chem., March 12, 1999; 274(11): 7011 - 7017. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1981 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |